Yong Rong (Hk) Asset Management LTD Regeneron Pharmaceuticals, Inc. Transaction History

Yong Rong (Hk) Asset Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 19, 2020	SELL	$274.13 - $376.51 $2.74 Million - $3.77 Million	-10,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $3 Million - $4.15 Million	10,000 New	10,000 $3.13 Million
Q4 2018 Feb 14, 2019	SELL	$335.82 - $403.04 $4.03 Million - $4.84 Million	-12,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$284.6 - $344.99 $1.28 Million - $1.55 Million	4,500 Added 60.0%	12,000 $4.14 Million
Q1 2018 May 11, 2018	BUY	$315.82 - $393.78 $2.37 Million - $2.95 Million	7,500 New	7,500 $2.58 Million

1,483

85.7M

908K

1.3M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $88.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Yong Rong (Hk) Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Yong Rong (Hk) Asset Management LTD with notifications on news.